GoodCap
1 known investors
GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
Founders & leadership
DH
Darryl HudsonCo-founder
Investors Β· 1
Frequently asked questions
- What does GoodCap do?
- GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
- Who founded GoodCap?
- GoodCap was founded by Darryl Hudson.
- Who are GoodCap's investors?
- GoodCap's investors include JLS.